357 related articles for article (PubMed ID: 11908944)
1. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.
Christianson SW; Greiner DL; Deluca D; Leif J; Phillips NE; Hayes SM; Hayashi S; Joliat MJ; Lyons BL; Shultz LD
J Autoimmun; 2002 Mar; 18(2):119-30. PubMed ID: 11908944
[TBL] [Abstract][Full Text] [Related]
2. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.
Joliat MJ; Lang PA; Lyons BL; Burzenski L; Lynes MA; Yi T; Sundberg JP; Shultz LD
J Autoimmun; 2002 Mar; 18(2):105-17. PubMed ID: 11908943
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration.
Lyons BL; Smith RS; Hurd RE; Hawes NL; Burzenski LM; Nusinowitz S; Hasham MG; Chang B; Shultz LD
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1201-9. PubMed ID: 16505059
[TBL] [Abstract][Full Text] [Related]
4. Localization of prothymocytes from wild-type and viable motheaten mice following intravenous injection into irradiated adoptive recipients.
Hayes SM; Shultz LD; Greiner DL
Cell Immunol; 1994 Feb; 153(2):344-55. PubMed ID: 8118868
[TBL] [Abstract][Full Text] [Related]
5. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.
Huang Z; Coleman JM; Su Y; Mann M; Ryan J; Shultz LD; Huang H
Cytokine; 2005 Feb; 29(3):118-24. PubMed ID: 15613279
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell protein-tyrosine phosphatase-deficient motheaten mice exhibit T cell apoptosis defect.
Su X; Zhou T; Yang PA; Wang Z; Mountz JD
J Immunol; 1996 Jun; 156(11):4198-208. PubMed ID: 8666788
[TBL] [Abstract][Full Text] [Related]
7. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
8. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.
Tapley P; Shevde NK; Schweitzer PA; Gallina M; Christianson SW; Lin IL; Stein RB; Shultz LD; Rosen J; Lamb P
Exp Hematol; 1997 Feb; 25(2):122-31. PubMed ID: 9015212
[TBL] [Abstract][Full Text] [Related]
9. src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.
Kamata T; Yamashita M; Kimura M; Murata K; Inami M; Shimizu C; Sugaya K; Wang CR; Taniguchi M; Nakayama T
J Clin Invest; 2003 Jan; 111(1):109-19. PubMed ID: 12511594
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the development of T cells by transferring precursors into cultured fetal thymus with a microinjector.
Watanabe Y; Gyotoku J; Katsura Y
Thymus; 1989; 13(1-2):57-71. PubMed ID: 2516372
[TBL] [Abstract][Full Text] [Related]
11. Sox-4 facilitates thymocyte differentiation.
Schilham MW; Moerer P; Cumano A; Clevers HC
Eur J Immunol; 1997 May; 27(5):1292-5. PubMed ID: 9174623
[TBL] [Abstract][Full Text] [Related]
12. Developmental ages of the thymic epithelium and of the T cell precursors together determine the proportions of peripheral CD4+ cells.
Adkins B; Hamilton K
J Immunol; 1994 Dec; 153(12):5359-65. PubMed ID: 7989742
[TBL] [Abstract][Full Text] [Related]
13. Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro.
Medlock ES; Goldschneider I; Greiner DL; Shultz L
J Immunol; 1987 Jun; 138(11):3590-7. PubMed ID: 3584969
[TBL] [Abstract][Full Text] [Related]
14. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
White ED; Andrews RP; Hershey GK
J Leukoc Biol; 2001 May; 69(5):825-30. PubMed ID: 11358992
[TBL] [Abstract][Full Text] [Related]
15. Fetal thymi from diabetes-prone but not diabetes-resistant BB/Wor rats fail to generate mature ART2+ T-cells in organ culture.
Zipris D; Leif J; Deluca D; Lin MY; Mordes JP; Rossini AA; Greiner DL; Whalen BJ
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):65-74. PubMed ID: 11292261
[TBL] [Abstract][Full Text] [Related]
16. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of T cell receptor ligation of TCR gamma delta thymocyte development in fetal thymic organ culture.
Tatsumi Y; Deluca D; Cron RQ; Bluestone JA
Thymus; 1994-1995; 23(3-4):131-53. PubMed ID: 8525502
[TBL] [Abstract][Full Text] [Related]
18. Defective in vitro migratory capacity of bone marrow cells from viable motheaten mice in response to normal thymus culture supernatants.
Haar JL; Popp JD; Shultz LD
Exp Hematol; 1989 Jan; 17(1):21-4. PubMed ID: 2562796
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of thymic NK1.1+ cells.
Ballas ZK; Rasmussen WL; Alber CA; Sandor M
J Immunol; 1997 Aug; 159(3):1174-81. PubMed ID: 9233611
[TBL] [Abstract][Full Text] [Related]
20. Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia.
Beamer CA; Brooks DM; Lurie DI
J Neurosci Res; 2006 May; 83(7):1220-30. PubMed ID: 16528752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]